Download PDF

Other users also viewed these articles

Efficacy and safety of using Elexacaftor/Tezacaftor/Ivacaftor in the treatment of children with cystic fibrosis: real-world evidence from Brazil Guilherme da Silva Martins; Carolina Rambo; Gabriela Spessatto; Maitê Milagres Saab; Bruno Hernandes David João; Aline Didoni Fajardo; Juliana Gonçalves Primon; Thalita Gonçalves Picciani; Roberta Corrêa da Cunha; Herberto José Chong-Neto; Carlos Roberto Lebarbenchon Massignan; Luiz Vicente Ribeiro Ferreira da Silva-Filho; Carlos Antônio Riedi; Nelson Augusto Rosário Filho; Débora Carla Chong-Silva;
J Pediatr (Rio J). 2025;101:
Prognostic nutritional index as a biomarker for identifying coronary artery lesions in Kawasaki disease Chao Zhang; Guoshun Mao; Guosheng Hu;
J Pediatr (Rio J). 2025;101:
A comparative study of serum and fecal calprotectin levels in necrotizing enterocolitis Sara Erol; Cuneyt Tayman; Sabriye Korkut; Ufuk Çakir; Abdullah Kurt; Ismail Koyuncu;
J Pediatr (Rio J). 2025;101: